Judge Approves $150M Flonase Antitrust Accord
A Pennsylvania federal judge on Friday approved a $150 million settlement, including $50 million in attorneys' fees, ending a direct purchaser antitrust class action accusing GlaxoSmithKline of filing sham petitions with...To view the full article, register now.
Already a subscriber? Click here to view full article